Objective Biotechnology is focused on advancing biological research through innovative technologies that facilitate the measurement and manipulation of biological systems. One of their key offerings is a suite of neurotechnology tools designed for large-scale optical access and neural recordings in rodent models, allowing researchers to study brain functions during unrestrained behavior. Additionally, the company has developed an automated microinjection system that streamlines genetic manipulation processes, significantly enhancing the efficiency and scalability of experiments involving cells and organisms.

The company also features specialized products such as optimized micropipettes tailored for their autoinjector, which are designed to ensure the best results in automated microinjection. Their advancements have garnered recognition, including awards and grants, highlighting their impact in the fields of genetics and neuroscience. Notably, their automated microinjection technology, powered by machine learning, has been recognized for its potential to save time and resources in genetic research, while a unique mini-microscope allows for real-time imaging of complex brain functions in freely moving mice, further pushing the boundaries of neuroscience research.

United States

Objective Biotechnology's mission is to develop high-impact technologies that enable comprehensive measurement and manipulation of biological systems at multiple scales, unlocking new research capabilities.

Objective Biotechnology

Company Details